FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W344510317> ?p ?o ?g. }

• W344510317 endingPage "361" @default.
• W344510317 startingPage "343" @default.
• W344510317 abstract "Evidence suggests that combined gemcitabine-cisplatin chemotherapy extends survival in patients with advanced biliary tract cancer (BTC). We conducted a systematic review in order to collate this evidence and assess whether gemcitabine-cisplatin efficacy is influenced by primary tumor site, disease stage, or geographic region, and whether associated toxicities are related to regimen. MEDLINE (1946-search date), EMBASE (1966-search date), ClinicalTrials. gov (2008-search date), and abstracts from major oncology conferences (2009- search date) were searched (5 Dec 2013) using terms for BTC, gemcitabine, and cisplatin. All study types reporting efficacy (survival, response rates) or safety (toxicities) outcomes of gemcitabine-cisplatin in BTC were eligible for inclusion; efficacy data were extracted from prospective studies only. Evidence retrieved from one meta-analysis (abstract), four randomized controlled trials, 12 nonrandomized prospective studies, and three retrospective studies supported the efficacy and safety of gemcitabine-cisplatin for BTC. Median overall survival ranged from 4.6 to 11.7 months, and response rate ranged from 17.1% to 36.6%. Toxicities were generally acceptable and manageable. Heterogeneity in study designs and data collected prevented formal meta-analysis, however exploratory assessments suggested that efficacy did not vary with primary tumor site (gallbladder vs. others), disease stage (metastatic vs. locally advanced), or geographic origin (Asia vs. other). Incidence of grade 3/4 toxicities was not related to gemcitabine dose or cisplatin frequency. Despite individual variation in study designs, the evidence presented suggests that gemcitabine-cisplatin is effective in patients from a diverse range of countries and with heterogeneous disease characteristics. No substantial differences in toxicity were observed among the different dosing schedules of gemcitabine and cisplatin." @default.
• W344510317 created "2016-06-24" @default.
• W344510317 creator A5015598872 @default.
• W344510317 creator A5018333718 @default.
• W344510317 creator A5028033679 @default.
• W344510317 creator A5045587524 @default.
• W344510317 creator A5047892072 @default.
• W344510317 creator A5053209984 @default.
• W344510317 creator A5059766169 @default.
• W344510317 creator A5074026718 @default.
• W344510317 date "2015-05-18" @default.
• W344510317 modified "2023-10-04" @default.
• W344510317 title "Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review" @default.
• W344510317 cites W176192244 @default.
• W344510317 cites W1990738112 @default.
• W344510317 cites W1996484986 @default.
• W344510317 cites W1996520070 @default.
• W344510317 cites W2001168894 @default.
• W344510317 cites W2001540794 @default.
• W344510317 cites W2011387799 @default.
• W344510317 cites W2025400307 @default.
• W344510317 cites W2025769688 @default.
• W344510317 cites W2029037503 @default.
• W344510317 cites W2045950774 @default.
• W344510317 cites W2046685969 @default.
• W344510317 cites W2065134430 @default.
• W344510317 cites W2072277700 @default.
• W344510317 cites W2078189576 @default.
• W344510317 cites W2081498029 @default.
• W344510317 cites W2084530595 @default.
• W344510317 cites W2087336559 @default.
• W344510317 cites W2087350855 @default.
• W344510317 cites W2097968583 @default.
• W344510317 cites W2101465269 @default.
• W344510317 cites W2104487249 @default.
• W344510317 cites W2107842546 @default.
• W344510317 cites W2107894073 @default.
• W344510317 cites W2112347626 @default.
• W344510317 cites W2115261608 @default.
• W344510317 cites W2117834374 @default.
• W344510317 cites W2119700454 @default.
• W344510317 cites W2128889451 @default.
• W344510317 cites W2135849593 @default.
• W344510317 cites W2136264959 @default.
• W344510317 cites W2136797122 @default.
• W344510317 cites W2145534346 @default.
• W344510317 cites W2149422956 @default.
• W344510317 cites W2154711900 @default.
• W344510317 cites W2155637224 @default.
• W344510317 cites W2158939683 @default.
• W344510317 cites W2168106806 @default.
• W344510317 cites W2401765700 @default.
• W344510317 cites W81033190 @default.
• W344510317 doi "https://doi.org/10.4143/crt.2014.308" @default.
• W344510317 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4509359" @default.
• W344510317 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25989801" @default.
• W344510317 hasPublicationYear "2015" @default.
• W344510317 type Work @default.
• W344510317 sameAs 344510317 @default.
• W344510317 citedByCount "66" @default.
• W344510317 countsByYear W3445103172016 @default.
• W344510317 countsByYear W3445103172017 @default.
• W344510317 countsByYear W3445103172018 @default.
• W344510317 countsByYear W3445103172019 @default.
• W344510317 countsByYear W3445103172020 @default.
• W344510317 countsByYear W3445103172021 @default.
• W344510317 countsByYear W3445103172022 @default.
• W344510317 countsByYear W3445103172023 @default.
• W344510317 crossrefType "journal-article" @default.
• W344510317 hasAuthorship W344510317A5015598872 @default.
• W344510317 hasAuthorship W344510317A5018333718 @default.
• W344510317 hasAuthorship W344510317A5028033679 @default.
• W344510317 hasAuthorship W344510317A5045587524 @default.
• W344510317 hasAuthorship W344510317A5047892072 @default.
• W344510317 hasAuthorship W344510317A5053209984 @default.
• W344510317 hasAuthorship W344510317A5059766169 @default.
• W344510317 hasAuthorship W344510317A5074026718 @default.
• W344510317 hasBestOaLocation W3445103171 @default.
• W344510317 hasConcept C121608353 @default.
• W344510317 hasConcept C126322002 @default.
• W344510317 hasConcept C143998085 @default.
• W344510317 hasConcept C2776694085 @default.
• W344510317 hasConcept C2778239845 @default.
• W344510317 hasConcept C2780258809 @default.
• W344510317 hasConcept C2781413609 @default.
• W344510317 hasConcept C71924100 @default.
• W344510317 hasConceptScore W344510317C121608353 @default.
• W344510317 hasConceptScore W344510317C126322002 @default.
• W344510317 hasConceptScore W344510317C143998085 @default.
• W344510317 hasConceptScore W344510317C2776694085 @default.
• W344510317 hasConceptScore W344510317C2778239845 @default.
• W344510317 hasConceptScore W344510317C2780258809 @default.
• W344510317 hasConceptScore W344510317C2781413609 @default.
• W344510317 hasConceptScore W344510317C71924100 @default.
• W344510317 hasIssue "3" @default.
• W344510317 hasLocation W3445103171 @default.
• W344510317 hasLocation W3445103172 @default.
• W344510317 hasLocation W3445103173 @default.

• next